Noninvasive imaging of atherosclerosis: The biology behind the pictures

Journal of Nuclear Medicine

Volumn 45, Issue 11, 2004, Pages 1794-1795

  Weissberg, Peter L ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANGIOGRAPHY; ATHEROSCLEROSIS; CALCIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; HEART INFARCTION; HUMAN; KIDNEY DISEASE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY; ARTERIOSCLEROSIS; ARTICLE; CALCINOSIS; METABOLISM; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ARTERIOSCLEROSIS; CALCINOSIS; FLUORODEOXYGLUCOSE F18; HUMANS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 16244397266     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
2. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
3. 18F-FDG PET/CT. J Nucl Med. 2004;45:1816-1821.
4. Proudfoot D, Shanahan CM, Weissberg PL. Vascular calcification: new insights into an old problem. J Pathol. 1998;185:1-3.
5. Budoff MJ, Shavelle DM, Lamont DH, et al. Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy. J Am Coll Cardiol. 1998;32:1173-1178.
6. Bleeker-Rovers C, Bredie S, van der Meer J, Corstens F, Oyen W. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med. 2003;61:323-329.
7. Andrews J, Al-Nahhas A, Pennell D, et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 2004;63:995-1000.
8. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
9. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001;103:926-933.
10. Fukumoto Y, Libby P, Rabkin E, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation. 2001;103:993-999.
11. Weissberg PL. Atherogenesis: current understanding of the causes of atheroma. Heart. 2000;83:247-252.
12. Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 1996;149:367-380.
13. Boyle J, Bowyer D, Weissberg P, Bennett M. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler Thromb Vasc Biol. 2001;21:1402-1407.
14. Geng Y, Wu Q, Muszynski M, Hansson G, Libby P. Apoptosis of vascular smooth-muscle cells induced by in vitro stimulation with interferongamma, tumor necrosis factor-alpha, and interleukin-1-beta. Arterioscler Thromb Vasc Biol. 1996;16:19-27.
15. Proudfoot D, Skepper JN, Hegyi L, Farzaneh-Far A, Shanahan CM, Weissberg PL. The role of apoptosis in the initiation of vascular calcification. Z Kardiol. 2001;90(suppl 3):43-46.
16. Tyson K, Reynolds J, McNair R, Zhang Q, Weissberg P, Shanahan CM. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003;23:489-494.